Novel mechanisms of EBV-induced oncogenesis

doi:10.1016/j.coviro.2012.07.001

Review

. 2012 Aug;2(4):453-8.

doi: 10.1016/j.coviro.2012.07.001. Epub 2012 Aug 1.

Novel mechanisms of EBV-induced oncogenesis

Nancy Raab-Traub¹

Affiliations

Affiliation

¹ Sarah Graham Kenan Distinguished Professor, Department of Microbiology & Immunology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7295, USA. nrt@med.unc.edu

PMID: 22858118
PMCID: PMC4617531
DOI: 10.1016/j.coviro.2012.07.001

Review

Novel mechanisms of EBV-induced oncogenesis

Nancy Raab-Traub. Curr Opin Virol. 2012 Aug.

. 2012 Aug;2(4):453-8.

doi: 10.1016/j.coviro.2012.07.001. Epub 2012 Aug 1.

Author

Nancy Raab-Traub¹

Affiliation

¹ Sarah Graham Kenan Distinguished Professor, Department of Microbiology & Immunology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7295, USA. nrt@med.unc.edu

PMID: 22858118
PMCID: PMC4617531
DOI: 10.1016/j.coviro.2012.07.001

Abstract

Epstein-Barr virus is an etiologic factor in multiple types of cancer that primarily develop in lymphocytes and epithelial cells. The tumors are latently infected yet express distinct subsets of viral proteins that are essential for transformation. The viral oncogenes may be expressed in a subset of cells and are transferred through exosomes to many cells to induce growth and alter the tumor environment. In some of the viral cancers, viral proteins are not expressed, however, the viral miRNAs can alter growth by decreasing expression of negative regulators of cell growth such as tumor suppressors and cellular proteins that induce apoptosis.

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Cited by

Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.
Eberly HW, Sciscent BY, Lorenz FJ, Rettig EM, Goyal N. Eberly HW, et al. Biomedicines. 2024 Feb 10;12(2):415. doi: 10.3390/biomedicines12020415. Biomedicines. 2024. PMID: 38398017 Free PMC article. Review.
Biomarker driven treatment of head and neck squamous cell cancer.
Eze N, Lo YC, Burtness B. Eze N, et al. Cancers Head Neck. 2017 Aug 29;2:6. doi: 10.1186/s41199-017-0025-1. eCollection 2017. Cancers Head Neck. 2017. PMID: 31093353 Free PMC article. Review.
Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.
Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, Yoshizaki T, Pagano JS, Shackelford J. Aga M, et al. Oncogene. 2014 Sep 11;33(37):4613-22. doi: 10.1038/onc.2014.66. Epub 2014 Mar 24. Oncogene. 2014. PMID: 24662828 Free PMC article.
A short overview of CRISPR-Cas technology and its application in viral disease control.
Ghorbani A, Hadifar S, Salari R, Izadpanah K, Burmistrz M, Afsharifar A, Eskandari MH, Niazi A, Denes CE, Neely GG. Ghorbani A, et al. Transgenic Res. 2021 Jun;30(3):221-238. doi: 10.1007/s11248-021-00247-w. Epub 2021 Apr 8. Transgenic Res. 2021. PMID: 33830423 Free PMC article. Review.
The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications.
Yang L, Liu G, Li Y, Pan Y. Yang L, et al. Genes Dis. 2021 Aug 8;9(5):1208-1219. doi: 10.1016/j.gendis.2021.07.002. eCollection 2022 Sep. Genes Dis. 2021. PMID: 35873027 Free PMC article. Review.

See all "Cited by" articles

References

1. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1:702–703. - PubMed
1. Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, et al. Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J Natl Cancer Inst. 1969;43:1147–1157. - PubMed
1. Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970;44:225–231. - PubMed
1. Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968;59:94–101. - PMC - PubMed
1. Raab-Traub N. EBV-induced oncogenesis. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 2007. - PubMed

Publication types

Actions
Actions

MeSH terms

Substances

Actions

Grants and funding

CA138811/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources

[1] Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1:702–703. - PubMed

[2] Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1:702–703. - PubMed

[3] Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, et al. Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J Natl Cancer Inst. 1969;43:1147–1157. - PubMed

[4] Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, et al. Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J Natl Cancer Inst. 1969;43:1147–1157. - PubMed

[5] Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970;44:225–231. - PubMed

[6] Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970;44:225–231. - PubMed

[7] Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968;59:94–101. - PMC - PubMed

[8] Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968;59:94–101. - PMC - PubMed

[9] Raab-Traub N. EBV-induced oncogenesis. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 2007. - PubMed

[10] Raab-Traub N. EBV-induced oncogenesis. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 2007. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Novel mechanisms of EBV-induced oncogenesis

Affiliation

Novel mechanisms of EBV-induced oncogenesis

Author

Affiliation

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources